39 results on '"McGuire, John"'
Search Results
2. Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases
3. Angiotensin II Type 1 Receptor Antagonist Azilsartan Restores Vascular Reactivity Through a Perivascular Adipose Tissue-Independent Mechanism in Rats with Metabolic Syndrome
4. Studies on the Cross-Resistance of Folylpolyglutamate Synthetase-Deficient, Methotrexate-Resistant CCRF-CEM Human Leukemia Sublines
5. Panel Discussion of Future Directions
6. In Vitro Methotrexate Polyglutamate Synthesis by Rat Liver Folylpolyglutamate Synthetase and Inhibition by Bromosulfophthalein
7. Summation of Session 1
8. Effective Salvage Therapy for Refractory Disseminated Breast Cancer with 5-Fluorouracil and High-Dose Continuous Infusion Folinic Acid
9. A Controlled Clinical Trial Including Folinic Acid at Two Distinct Dose Levels in Combination with 5-Fluorouracil (5FU) for the Treatment of Advanced Colorectal Cancer: Experience of the Mayo Clinic and North Central Cancer Treatment Group
10. 5-Fluorouracil and 5-Formyltetrahydrofolate in Advanced Malignancies
11. 5-Fluorouracil and Folinic Acid: Summary of Clinical Experience
12. Clinical Experience with 5-FU/DDP ± OHDW Combination Chemotherapy in Patients with Advanced Colorectal Carcinoma
13. Progress Report on Studies of FAM-CF for Gastric Cancer and Intraperitoneal Administration of FUra-CF Followed by Cisplatin (DDP)
14. Folinic Acid (CF)/5-Fluorouracil (FUra) Combinations in Advanced Gastrointestinal Carcinomas
15. 5-Fluorouracil/Folinic Acid/Cisplatin-Combination and Simultaneous Accelerated Split-Course Radiotherapy in Advanced Head and Neck Cancer
16. Adjuvant Therapy for Colorectal Cancer: The NSABP Clinical Trials
17. Chemotherapy of Advanced and Relapsed Squamous Cell Cancer of the Head and Neck with Split-Dose Cisplatinum (DDP), 5-Fluorouracil (Fura) and Leucovorin (CF)
18. The Roswell Park Memorial Institute and Gastrointestinal Tumor Study Group Phase III Experience with the Modulation of 5-Fluorouracil by Leucovorin in Metastatic Colorectal Adenocarcinoma
19. Progress Report on a Phase II Trial of 5-Fluorouracil Plus Citrovorum Factor in Women with Metastatic Breast Cancer
20. Mechanisms for Cisplatin-FUra Synergism and Cisplatin Resistance in Human Ovarian Carcinoma Cells both in vitro and in vivo
21. Clinical Experience with CF-FUra
22. Pharmacodynamics of 5-Fluorouracil and Leucovorin
23. A Randomized Trial of 5-Fluorouracil Alone Versus 5-Fluorouracil and High Dose Leucovorin in Untreated Advanced Colorectal Cancer Patients
24. A Northern California Oncology Group Randomized Trial of Single Agent 5-FU vs. High-Dose Folinic Acid + 5-FU vs. Methotrexate + 5-FU + Folinic Acid in Patients with Disseminated Measurable Large Bowel Cancer
25. 5-Fluorouracil (FUra) and Folinic Acid (FA) Therapy in Patients with Colorectal Cancer
26. Selectivity of CF and 5-Fluorouracil: Critical Role of Polyglutamylation
27. High-Dose Weekly Oral Leucovorin and 5-Fluorouracil in Previously Untreated Patients with Advanced Colorectal Carcinoma: A Phase I Study
28. Mount Sinai Clinical Experience with Leucovorin and 5-Fluorouracil
29. Methods for Thymidylate Synthase Pharmacodynamics: Serial Biopsy, Free and Total TS, FdUMP and dUMP, and H4PteGlu and CH2-H4PteGlu Assays
30. Tumor Cell Responses to Inhibition of Thymidylate Synthase
31. The Role of Thymidylate Synthase in the Response to Fluoropyrimidine-Folinic Acid Combinations
32. The Treatment of Metastatic Breast Cancer with 5-Fluorouracil and Leucovorin
33. Pharmacokinetic Analysis of (6S)-5-Formyltetrahydrofolate (1-CF), (6R)-5-Formyltetrahydrofolate (d-CF) and 5-Methyltetrahydrofolate (5-CH3-THF) in Patients Receiving Constant i.v. Infusion of High-Dose (6R,S)-5-Formyltetrahydrofolate (Leucovorin)
34. Thymidylate Synthase and Fluorouracil
35. Role of Dosf, Schedule and Route of Administration of 5-Formyltetra-Hydrofolate: Preclinical and Clinical Investigations
36. Overview: Rational Basis for Development of Fluoropyrimidine/5-Formyltetrahydrofolate Combination Chemotherapy
37. The Natural and Unnatural Diastereomers of Leucovorin: Aspects of their Cellular Pharmacology
38. Distribution and Metabolism of Calcium Leucovorin in Normal and Tumor Tissue
39. Summation of Session II
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.